Substance P and Analogs Thereof As a Cancer Immunogenic Composition Adjuvant
Disclosed herein are methods and compositions effective for treating, preventing, and ameliorating cancer that utilize Substance P or Substance P analogs and antigens. Also disclosed are methods for vaccinating a patient against cancer that utilize Substance P or Substance P analogs and antigens.
Patents:WO 2,009,129,498
Inventor(s):
WILHELM MICHAEL KLAUS [US]; SIEGEL HAL N [US]; LARREGINA ADRIANA T [US]; MORELLI ADRIAN EDUARDO [US]
Type of Offer:
Licensing
« More Biotech Patents